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Abstract
Aim For accurate interpretation of echocardiographic mea-
surements normative data are required, which are provided
by guidelines. For this article, the hypothesis was that these
cannot be extrapolated to the Dutch population, since in
Dutch clinical practice often higher values are found, which
may not be pathological but physiological. Therefore this
study aimed to 1) obtain and propose normative values for
cardiac chamber quantification in a healthy Dutch popula-
tion and 2) determine influences of baseline characteristics
on these measurements.
Methods Prospectively recruited healthy subjects, aged
20–72 years (at least 28 subjects per age decade, equally
distributed for gender) underwent physical examination
and 2D and 3D echocardiography. Both ventricles and atria
were assessed and volumes were calculated.
Results 147 subjects were included (age 44 ± 14 years,
50% female). Overall, feasibility was good for both linear
and volumetric measurements. Linear and volumetric pa-
rameters were consistently higher than current guidelines
recommend, while functional parameters were in line with
the guidelines. This was more so in the older population. 3D
volumes were higher than 2D volumes. Gender dependency
was seen in all body surface area (BSA) corrected volumes
and with increasing age, ejection fractions decreased.
Conclusion This study provides 2D and 3D echocardio-
graphic reference ranges for both ventricles and atria de-
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rived from a healthy Dutch population. BSA indexed vol-
umes are gender-dependent, age did not influence ventricu-
lar volumes and a rise in blood pressure was independently
associated with increased right ventricular volumes. The
higher volumes found may be indicative for the Dutch pop-
ulation being the tallest in the world.
Keywords Echocardiography · 3D · Normal values ·
Chamber quantification
Introduction
Echocardiography is indispensable in clinical practice. It is
the most widely used non-invasive imaging tool to assess
and quantify cardiac structural and functional parameters,
mainly because of its versatility: it is widely available, rela-
tively cost-effective and mobile. To interpret the performed
measurements, solid normative data are essential. The re-
cently revised guideline for cardiac chamber quantification
provides guidance for echocardiographic assessment [1, 2].
For some measurements, age- and gender-specific values
are reported.
In the literature, there are four studies that show an in-
fluence of gender and age on left ventricular (LV) and right
ventricular (RV) volumes [3]. However, besides age and
gender, there are implications that ethnicity also influences
cardiac size and function [4–7]. Echocardiographic mea-
surements performed in healthy Dutch people, the tallest
people worldwide [8], often supersede the upper limits of
normal (ULN) given by current guidelines though most in-
dices are corrected with body surface area (BSA). This
implies that BSA correction does not fully equalise dif-
ferences originating from height. Also, a study comparing
Caucasians with Asian Indians showed smaller 3D LV vol-
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Fig. 1 Measurements of RV dimensions. The RV basal (D1) and mid cavity (D2) dimensions are shown in the RV focused apical four-chamber
view (a). Measurements of the right ventricular outflow tract at the proximal level and the distal level are shown in the parasternal short-axis (b)
and parasternal long-axis view (c)
Fig. 2 Flowchart depicting the
inclusion and feasibility of the
performed measurements
Eligible volunteers
n = 155
Eligible volunteers
n = 147
Excluded (n = 8)
• Breast implants (n = 2)
• Valvular pathology (n = 2)
• Surgically closed ductus (n = 1)
• Hypertension (n = 1)
• Morbid obesity (n = 1)
• Right bundle branch block (n = 1)
3D Feasibility
LV: 121 (82.3%)
RV: 97 (66.0%)
2D Feasibility
LA: 136 (92.6%)
RA: 130 (88.4%)
LV: 121 (82.3%)
RV: 97 (66.0%)
umes in Asians but with a comparable ejection fraction
(EF). However, ethnic-specific normal values for the Dutch
population are not yet available.
Therefore, this study aims to provide 1) age-specific
reference values for echocardiographic chamber measure-
ments specifically in a Dutch population and 2) identify the
influence of age, gender, body mass index (BMI), BSA and
blood pressure on the echocardiographic measurements.
Methods
Patient population
Healthy volunteers, aged 20–72 years, were enrolled in
2014–2015 for this prospective cross-sectional study and
were stratified into five groups: 20–29, 30–39, 40–49,
50–59 and 60–72 years (each 50% female). Details have
been published earlier [9]. Healthy subjects were examined
at the cardiology outpatient clinic of the Erasmus Medical
Centre, Rotterdam. Exclusion criteria were: (prior) cardio-
vascular disease, systemic disease, or cardiac medication,
the finding of cardiac abnormalities during examination or
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Table 1 Baseline characteristics
Total population Male Female
n = 147 n = 73 n = 74
Age (years) 44.6 ± 13.8 44.0 ± 13.7 45.3 ± 13.8
Height (cm) 175 ± 9 181 ± 7 169 ± 6
Weight (kg) 75 ± 13 82 ± 11 67 ± 9
Body mass index (kg/m2) 24.4 ± 3.3 25.2 ± 3.3 23.6 ± 3.0
Body surface area (m2) 1.89 ± 0.19 2.03 ± 0.15 1.76 ± 0.12
Systolic blood pressure (mm Hg) 127 ± 15 131 ± 16 123 ± 12
Diastolic blood pressure (mm Hg) 80 ± 9 82 ± 9 77 ± 9
Heart rate (beats per minute) 71 ± 12 69 ± 12 72 ± 12
cardiovascular risk factors consisting of hypertension (sys-
tolic and diastolic blood pressure >140/80 mm Hg), diabetes
mellitus and hypercholesterolaemia. Professional athletes,
morbidly obese subjects (BMI >40 kg/m2), pregnant women
and women with breast implants were excluded. This study
was carried out according to the principles of the Declara-
tion of Helsinki and approved by the local ethics committee.
Written informed consent was obtained from all patients.
Clinical assessment
The study consisted of a questionnaire on medical history
and health status, physical examination, venous blood sam-
pling, 12-lead electrocardiogram and an echocardiogram.
Echocardiographic image acquisition
Echocardiographic studies were carried out by one of two
experienced sonographers. Two-dimensional greyscale har-
monic images were obtained in the left lateral decubitus
position using an i33 or EPIQ7 ultrasound system (Philips
Medical Systems, Best, the Netherlands) equipped with
a transthoracic broadband X5-1 matrix transducer (com-
posed of 3,040 elements with 1–5 MHz). Dedicated views
were taken for assessment of both atria and ventricles. The
studies were stored in Digital Imaging and Communications
in Medicine (DICOM) format.
Echocardiographic measurements
The current recommendations for chamber quantification
were used [1]. LV end-diastolic and -systolic diameters
were measured in the parasternal short axis view, together
with their respective volumes using the apical four- and
two-chamber views. Volumes were measured using the
method-of-disk summation technique.
The left atrial (LA) area was measured in dedicated atrial
four- and two-chamber views to avoid foreshortening. Bi-
plane volumes were measured using the method-of-disk
summation technique.
For the right ventricle, end-diastolic and -systolic areas
(EDA and ESA) were measured in order to calculate the
fractional area change:
FAC =
enddiastolicarea − endsystolicarea
enddiastolicarea
 100:
End-diastolic basal- and mid-cavity diameters were mea-
sured in the modified apical four-chamber view. The prox-
imal and distal outflow tract diameters were measured in
the parasternal short-axis view (Fig. 1). Tricuspid annular
plane systolic excursion (TAPSE) was measured.
For the right atrium, the single plane volume was mea-
sured in the apical four-chamber view using the method-of-
disk summation technique and the area length method.
Three-dimensional measurements
LV volumetric measurements were performed with TomTec
4D LV function suite (4D LV Analysis; TomTec Imaging
Systems, Unterschleissheim, Germany) using a semi-auto-
mated endocardial border trace, after the apex and the mid-
dle of the mitral valve annulus are determined by the oper-
ator. The end systolic and diastolic frame are automatically
detected in order to start contour detection. Corrections to
the endocardial trace were manually applied by the opera-
tor if needed. For the right ventricle, a similar routine was
used (TomTec 4D RV function; TomTec Imaging Systems,
Unterschleissheim, Germany).
Statistical analysis
Normal distribution was checked using Shapiro-Wilks tests
and histograms. Depending on data distribution, continu-
ous data are presented as mean ± standard deviation (SD)
or median with first-third quartile (Q1-Q3). Categorical
data are presented as frequencies and percentages. Student’s
t-test, the Mann-Whitney-U test, χ2-test or Fisher’s exact
test was used when appropriate. Correlations were mea-
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Table 2 Echocardiographic variables per age decade
Total popula-
tion
20–29 years 30–39 years 40–49 years 50–59 years 60–72 years
n = 147 n = 32 n = 28 n = 28 n = 31 n = 28 R p-value
2D measurements
Left ventricle
EDV (ml/m2) 62.4 ± 10.1 63.9 ± 9.5 63.1 ± 9.9 64.1 ± 11.0 60.5 ± 8.0 60.6 ± 12.2 ns 0.061
ESV (ml/m2) 24.9 ± 5.8 25.4 ± 5.1 24.7 ± 6.2 26.3 ± 5.5 23.2 ± 5.1 25.0 ± 6.9 ns 0.349
EF (%) 60.4 ± 4.7 60.4 ± 3.6 61.4 ± 5.0 59.2 ± 4.5 61.9 ± 5.3 59.2 ± 4.5 ns 0.596
EDD (mm) 46 ± 4 46 ± 3 47 ± 3 45 ± 4 45 ± 5 44 ± 5 0.248 0.003
ESD (mm) 28 ± 4 29 ± 3 28 ± 3 28 ± 5 28 ± 4 28 ± 6 ns 0.566
Right ventricle
EDA (cm2/m2) 13.2 ± 2.3 14.2 ± 2.3 13.5 ± 2.5 12.9 ± 1.8 12.3 ± 2.0 12.6 ± 2.4 0.275 0.001
ESA (cm2/m2) 7.7 ± 1.7 8.3 ± 1.6 7.7 ± 1.7 7.4 ± 1.6 7.3 ± 1.7 7.2 ± 2.0 0.219 0.014
FAC (%) 42.8 ± 7.3 41.2 ± 6.6 43.6 ± 6.2 42.6 ± 8.5 42.6 ± 8.7 44.5 ± 7.2 ns 0.198
D1 (mm) 39 ± 5 39 ± 5 38 ± 5 39 ± 6 38 ± 4 40 ± 6 ns 0.804
D2 (mm) 29 ± 5 30 ± 6 28 ± 4 31 ± 5 28 ± 5 30 ± 6 ns 0.795
RVOT proximal
PLAX (mm)
32 ± 4 30 ± 4 30 ± 4 31 ± 4 33 ± 5 34 ± 4 0.355 <0.001
RVOT proximal
SAX (mm)
31 ± 4 31 ± 4 30 ± 4 32 ± 4 32 ± 5 31 ± 3 0.174 0.047
RVOT distal
SAX (mm)
22 ± 3 22 ± 2 23 ± 2 21 ± 3 23 ± 2 23 ± 3 ns 0.326
Longitudinal
diameter
(mm)
82 ± 8 84 ± 7 86 ± 8 81 ± 8 81 ± 7 79 ± 7 0.181 0.029
TAPSE (mm) 26 ± 4 26 ± 4 27 ± 3 25 ± 4 26 ± 3 26 ± 4 ns 0.267
Left atrium
Length A4C
(mm)
5.0 ± 0.6 4.9 ± 0.6 5.0 ± 0.6 5.0 ± 0.5 5.1 ± 0.5 5.2 ± 0.7 ns 0.064
Area A4C
(cm2)
17.3 ± 3.2 16.6 ± 2.4 17.2 ± 3.0 17.1 ± 3.8 17.8 ± 2.4 17.8 ± 4.0 ns 0.134
Max volume
(ml/m2)
28.8 ± 7.2 27.8 ± 5.7 28.1 ± 6.6 29.0 ± 9.2 29.4 ± 5.5 30.0 ± 9.1 ns 0.170
Right atrium
Length (cm/m2) 2.6 ± 0.3 2.6 ± 0.3 2.6 ± 0.3 2.5 ± 0.3 2.6 ± 0.3 2.8 ± 0.3 ns 0.089
Area (cm/m2) 8.9 ± 1.5 8.8 ± 1.3 9.3 ± 1.5 8.5 ± 1.4 8.6 ± 1.7 9.2 ± 1.2 ns 0.866
Max volume
(ml/m2)
24.5 ± 7.0 24.4 ± 6.0 26.7 ± 8.4 23.3 ± 6.5 23.2 ± 7.9 24.8 ± 5.7 ns 0.343
3D measurements
Left ventricle
EDV (ml/m2) 77.5 ± 12.3 81.2 ± 12.1 77.1 ± 8.9 77.2 ± 10.7 75.6 ± 8.9 75.1 ± 18.9 ns 0.054
ESV (ml/m2) 33.9 ± 6.2 34.9 ± 6.2 32.9 ± 4.9 34.0 ± 5.2 33.4 ± 5.8 33.9 ± 8.8 ns 0.603
EF (%) 56.3 ± 3.7 57.0 ± 3.6 57.4 ± 3.1 55.9 ± 4.1 56.0 ± 4.3 54.8 ± 2.9 –0.229 0.012
Right ventricle
EDV (ml/m2) 57.7 ± 11.9 58.2 ± 14.3 54.9 ± 7.0 56.4 ± 12.1 58.5 ± 10.2 61.5 ± 15.0 ns 0.403
ESV (ml/m2) 24.3 ± 5.8 23.7 ± 6.8 22.7 ± 4.4 24.2 ± 6.0 24.3 ± 4.8 27.5 ± 6.5 ns 0.054
EF (%) 58.0 ± 4.2 59.1 ± 3.7 59.0 ± 4.3 57.3 ± 4.7 58.7 ± 4.1 54.9 ± 3.1 –0.298 0.003
EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, EDD end-diastolic diameter, ESD end-systolic diameter,
EDA end-diastolic area, ESA end-systolic area, FAC fractional area change, RVOT right ventricular outflow tract, SAX short-axis view,
TAPSE tricuspid annular plane systolic excursion.
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Table 3 Echocardiographic variables per gender
Total population Male Female
n = 147 n = 73 n = 74 p-value
2D measurements
Left ventricle
2D EDV (ml/m2) 62.4 ± 10.1 66.5 ± 9.3 58.6 ± 9.4 <0.001
2D ESV (ml/m2) 24.9 ± 5.8 27.2 ± 5.3 22.7 ± 5.3 <0.001
2D EF (%) 60.4 ± 4.7 59.2 ± 4.3 61.6 ± 4.8 0.002
EDD (mm) 46 ± 4 47 ± 4 45 ± 4 0.002
ESD (mm) 28 ± 4 29 ± 5 28 ± 4 0.026
Right ventricle
EDA (cm2/m2) 13.2 ± 2.3 13.9 ± 2.2 12.5 ± 2.2 <0.001
ESA (cm2/m2) 7.7 ± 1.7 8.2 ± 1.8 7.1 ± 1.6 <0.001
FAC (%) 42.8 ± 7.3 41.4 ± 7.7 44.0 ± 6.8 0.048
D1 (mm) 39 ± 5 41 ± 5 37 ± 4 <0.001
D2 (mm) 29 ± 5 32 ± 5 27 ± 5 <0.001
RVOT proximal PLAX (mm) 32 ± 4 33 ± 5 31 ± 4 0.037
RVOT proximal SAX (mm) 31 ± 4 32 ± 4 31 ± 4 0.013
RVOT distal SAX (mm) 22 ± 3 23 ± 3 22 ± 3 0.15
Longitudinal diameter (mm) 82 ± 8 85 ± 7 80 ± 7 0.014
TAPSE (mm) 26 ± 4 26 ± 4 26 ± 4 0.344
Left atrium
Length A4C (mm) 5.0 ± 0.6 5.2 ± 0.6 4.9 ± 0.6 0.019
Area A4C (cm2) 17.3 ± 3.2 17.8 ± 3.4 16.9 ± 2.8 0.086
Biplane max volume (ml/m2) 28.8 ± 7.2 27.9 ± 7.5 29.8 ± 6.9 0.135
Right atrium
Length (cm/m2) 2.6 ± 0.3 2.5 ± 0.3 2.7 ± 0.3 <0.001
Area (cm/m2) 8.9 ± 1.5 8.9 ± 1.6 8.8 ± 1.3 0.626
Single plane MOD max volume (ml/m2) 24.5 ± 7.0 25.8 ± 8.1 23.3 ± 5.7 0.038
3D measurements
Left ventricle
3D EDV (ml/m2) 77.5 ± 12.3 80.7 ± 13.6 74.2 ± 9.9 0.003
3D ESV (ml/m2) 33.9 ± 6.2 35.9 ± 6.7 31.8 ± 5.0 <0.001
3D EF (%) 56.3 ± 3.7 55.5 ± 3.3 57.1 ± 3.9 0.017
Right ventricle
3D EDV (ml/m2) 57.7 ± 11.9 61.3 ± 12.3 54.0 ± 10.4 0.002
3D ESV (ml/m2) 24.3 ± 5.8 26.0 ± 6.2 22.5 ± 4.9 0.003
3D EF (%) 58.0 ± 4.2 57.5 ± 4.1 58.4 ± 4.3 0.315
EDV end-diastolic volume, EF ejection fraction, EDD end-diastolic diameter, ESD end-systolic diameter, EDA end-diastolic area,
ESA end-systolic area, FAC fractional area change, RVOT right ventricular outflow tract, PLAX parasternal long-axis, SAX short-axis,
TAPSE tricuspid annular plane systolic excursion
sured using the Pearson correlation test. For correlations
between echocardiographic parameters and age, linear re-
gression analysis was applied. Variables that reached sig-
nificance and did not show collinearity with other variables
were included in a multivariable model. When collinearity
did occur, the variable with the highest correlation coeffi-
cient was included. A p  0.05 was considered statistically
significant. Statistical analysis was done using the Statis-
tical Package for Social Science version 21 (IBM DPDD
Statistics for Windows, Armonk, New York, USA).
Results
Of the 155 subjects eligible, 147 were included (mean age
44.6 ± 13.7 years, 50% female) (Fig. 2). Tab. 1 shows
the characteristics of the study population. LV volume and
function assessment with 3D echocardiography was feasi-
ble in 121 (82.3%) volunteers; RV volume and function
assessment with 3D echocardiography was feasible in 97
(66.0%) volunteers. Height, weight, BMI, BSA and sys-
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Fig. 3 Four charts depicting 2D measurements, the error bars are set at 2 SD. The solid and dotted lines represent the upper and lower limits
of normal as stated in the guideline. Left ventricular systolic and diastolic diameters per gender (a). Right ventricular linear measurements are
presented (b). Left ventricular 2D volumes are given per gender (c) as well as the right ventricular areas and fractional area change (d)
tolic and diastolic blood pressure were significantly lower
in women.
Echocardiographic chamber measurements in relation
with age
Tab. 2 presents an overview of echocardiographic parame-
ters per age decade. For 3D derived volumes, the averages
for the left ventricle were: end-diastolic volume (EDV) 78 ±
12 ml/m2 and end-systolic volume (ESV) 34 ± 6 ml/m2. For
the right ventricle, values were 58 ± 12 ml/m2 and 24 ±
6 ml/m2. LV and RV volumes were not age-dependent; this
was true for both 2D and 3D echocardiography. Age was in-
versely correlated with LVEF (57 ± 4 ml/m2 in the youngest
group and 55 ± 3 ml.m2 in the oldest group (r: –0.229, p:
0.012)). RVEF was 58 ± 4 ml/m2 and was not correlated
with age. Importantly, volumetric measurements acquired
with 2D echocardiography all exceeded the ULN as rec-
ommended in the guideline. This was also true for 3D LV
volumes, but not for the 3D RV volumes.
Echocardiographic chamber measurements in relation
with gender
Tab. 3 shows echocardiographic chamber measurements per
gender. Fig. 3 shows 2D measurements for both ventricles
(error bars at 2SD), with bars depicting the ULN (solid
line) or lower limit (dotted line) of normal according to
the guidelines [1]. Most of the measured variables showed
gender-dependency. 2D and 3D LV and RV dimensions
and volumes were gender-dependent. 2D and 3D EF was
also gender-dependent with the exception of 3D RVEF. Af-
ter BSA indexation, males had higher ventricular volumes.
BSA indexation of LA volume negated gender differences,
but BSA indexed right atrial (RA) volumes remained bigger
in men than women. On average, LA maximum volume was
28.8 ± 7.2 ml/m2, with 25% of the study population having
LA dilatation (>34 ml/m2) according to the guideline. In
this study, the ULN was 43.2 ml/m2.
Fig. 4 shows age- and gender-specific volumes for both
the LV and RV 3D data and the ULN according to the
guideline are again depicted. EF for both ventricles was
significantly correlated with age, EDV and ESV did not
correlate.
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Fig. 4 Four charts showing 2D and 3D derived left and right ventricular volumes and ejection fractions, for the entire study population and per
age group. The error bars are set at 2SD, and the solid lines represent the upper limits of normal according to the guideline
Correlations
BSA correlated strongest with echocardiographic parame-
ters compared with height, weight or BMI. Ventricular vol-
umes were not correlated with age, and LVEF and RVEF
showed a decrease with age. RV volumes showed a linear
increase with higher blood pressure and heart rate, also after
correcting for heart rate, QRS duration and gender.
Agreement between 2D and 3D for the LV measurements
was moderate: LV EDV: r: 0.643, p < 0.001, and LV ESV
r: 0.583, p < 0.001, respectively. For the RV correlations
between 2D volumes and 3D areas were weak: 3D EDV
vs 2D EDA r: 0.295, p: 0.004 and ESV r: 0.295, p: 0.005
respectively.
Discussion
This prospective study presents normative data for echocar-
diographic chamber quantification, age- and gender-spe-
cific, in a healthy Dutch population. Overall, linear and
volumetric parameters exceeded the ULN as stated in the
guideline, while functional parameters agreed with them.
BSA remains the best variable for indexation.
Feasibility
Feasibility of LV measurements in this study is in line with
previous studies [4, 10, 11]. Feasibility is important when
a technique is considered for clinical use and the percent-
ages in this study are good, especially since subjects with
a poor acoustic window were not excluded. The need for
implementation of 3D echocardiography for LV volume and
EF in clinical use is high. The lower feasibility for the right
ventricle was expected given its location in the thorax right
behind the sternum. Higher percentages have been reported
in the literature but poor acoustic windows were an exclu-
sion criterion whereas this was not the case for this study
[3].
Differences with guidelines
Comparing the results from this study to the ULN as stated
in the guideline[1], we found some discrepancies. For most
of the parameters, ULN of this study exceeded those of the
guideline. This was true for linear and volumetric measure-
ments, regardless of which ventricle or atrium the parameter
belonged to: both were larger, this is especially outspoken
in the elderly. For instance, when looking at 2D LV vol-
umes: the older the group, the larger the difference. The
higher linear and volumetric parameters found may be in-
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dicative to the Dutch people being the tallest people in the
world, which stresses the importance of specific normative
echocardiographic data for the Dutch population. Compar-
ing our data with results from the NORRE trial, a European
multicentre study pertaining to primarily white individuals,
we found that our volumes and dimensions were generally
higher [12]. Mean BSA in their study was 1.8 ± 0.2 vs our
1.89 ± 0.19 m2. This was due to both a higher weight (65 ±
12 vs 75 ± 13 kg) and height (169.8 ± 9.6 vs 175 ± 9 cm),
meaning that these higher values are not due to leaner sub-
jects.
Given that the Dutch population is the tallest worldwide
[8], the question arose whether BSA was the best parame-
ter for indexation. Univariate analysis in this study showed
that BSA correlated strongest when compared with height,
weight or BMI; it was indeed the best candidate for index-
ation. Most parameters exceeded the guideline, with one
exception: 3D derived volumes of the right ventricle were
in line with the guideline and current literature [3]. Func-
tional parameters concerning LV and RV systolic function
(EF, RV FAC and TAPSE) agreed with the proposed val-
ues in the guideline, meaning that the current guideline is
applicable for the Dutch population.
Multiple studies reported on the negative relation be-
tween age and echocardiographic LV volumes[10, 11, 13],
which is similar to what is seen in CMR studies [14, 15].
In this study, LV volumes did not decrease with age while
LVEF did. For the RV, there was no positive linear correla-
tion in RVEF as is reported by Maffessanti et al. (r 0.240,
p < 0.01) [3] , but a negative correlation. This probably
reached significance because of the lower mean RVEF in the
oldest group. Between the age groups 20–29 to 50–59 years,
values remain practically the same. Indeed, the correla-
tion between age and RVEF became stronger when the
study population was divided into groups 55 years and
>55 years. Maffessanti et al. reported similar values, but
in their cohort the oldest group (age >70 years) reported
higher values for RVEF. Perhaps RVEF does not increase
until old age (>70 years), which might explain why our
results are different. Clearly, the influence of age needs fur-
ther exploration.
Correlations with blood pressure
Hypertension was a reason for exclusion, but it is worth
mentioning that some volunteers had a higher blood pres-
sure but when checked again by a general practitioner were
found to be normal. These volunteers were not excluded.
Analysis showed that higher blood pressure led to higher
RV volumes. This could imply that sufficient blood pressure
regulation could influence the right ventricle.
Clinical implications
The reference values in this study could lead to some
changes in clinical decision-making. Though most guide-
lines use functional parameters, there are situations where
volumes or linear dimensions are being used. For instance,
when diagnosing LV diastolic dysfunction, LA dilatation
plays an important role [16]. With that in mind, in patients
suspected of heart failure with mid-range EF, LA enlarge-
ment is used to substantiate the diagnosis [17]. An enlarged
left atrium is also a strong prognosticator in, for instance,
in the recurrence of atrial fibrillation after surgery [18].
RV size is of particular importance for patients with adult
congenital heart disease. In patients with an atrial septal
defect, if the right ventricle is enlarged intervention is war-
ranted; this is also true for patients with ventricular septal
defect [19].
The impact is smaller regarding valvular disease; LV
linear dimensions are still used as opposed to volumes [20],
and values of LV linear dimensions in this study did agree
with guidelines.
Limitations
Considering the size and Dutch ethnicity of the study pop-
ulation, conclusions drawn should be interpreted with cau-
tion.
Conclusion
This study presents age- and gender-specific normative data
specifically for the native Dutch population, and reveals
that linear and volumetric parameters exceed the ULN
while functional parameters agree with the guideline. The
higher linear and volumetric parameters found may be
indicative to native Dutch people being the tallest people
worldwide. The authors suggest specific normative values
for echocardiographic assessment in the Dutch population.
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